FDA Approved: JOENJA — Original Application (Pharming Healthcare Inc.)

View source ↗

Summary

FDA approved JOENJA (leniolisib) from Pharming Healthcare Inc. under NDA217759 for activated PI3K delta syndrome, establishing a first-in-class targeted therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Activated Pi3k-delta Syndrome

Drugs mentioned

• JOENJA (leniolisib)

Snippet

ORIG AP for JOENJA (LENIOLISIB)